These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27108102)

  • 1. [Prevalence and initial management of overactive bladder in France: A cross-sectional study].
    Cornu JN; Amarenco G; Bruyere F; Chartier-Kastler E; Fatton B; Grise P; Haab F; Bourouina R
    Prog Urol; 2016 Jun; 26(7):415-24. PubMed ID: 27108102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
    Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
    BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
    Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
    J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
    Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
    Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.
    Milsom I; Kaplan SA; Coyne KS; Sexton CC; Kopp ZS
    Urology; 2012 Jul; 80(1):90-6. PubMed ID: 22748867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.
    Nik-Ahd F; Lenore Ackerman A; Anger J
    Curr Urol Rep; 2018 Sep; 19(11):94. PubMed ID: 30215140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical evaluation of the overactive bladder and urgency urinary incontinence association with obstructive sleep apnea syndrome in a relatively young adult male population.
    Tuncer M; Yazici O; Kafkasli A; Sabuncu K; Salepci B; Narter F; Gungor GA; Yucetas U
    Neurourol Urodyn; 2017 Sep; 36(7):1804-1808. PubMed ID: 27921319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National community prevalence of overactive bladder in the United States stratified by sex and age.
    Coyne KS; Sexton CC; Vats V; Thompson C; Kopp ZS; Milsom I
    Urology; 2011 May; 77(5):1081-7. PubMed ID: 21256571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of female prevalence of overactive bladder (OAB) in Barcelona using a self-administered screening questionnaire: the Cuestionario de Autoevaluación del Control de la Vejiga (CACV).
    Lugo Salcedo F; Sánchez Borrego R;
    Int Urogynecol J; 2013 Sep; 24(9):1559-66. PubMed ID: 23443344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overactive bladder syndrome among community-dwelling adults in Taiwan: prevalence, correlates, perception, and treatment seeking.
    Yu HJ; Liu CY; Lee KL; Lee WC; Chen TH
    Urol Int; 2006; 77(4):327-33. PubMed ID: 17135783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of overactive bladder syndrome and urinary incontinence in a Turkish women population; associated risk factors and effect on Quality of life.
    Sarici H; Ozgur BC; Telli O; Doluoglu OG; Eroglu M; Bozkurt S
    Urologia; 2016 May; 83(2):93-8. PubMed ID: 24803353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study.
    Chuang YC; Liu SP; Lee KS; Liao L; Wang J; Yoo TK; Chu R; Sumarsono B
    Low Urin Tract Symptoms; 2019 Jan; 11(1):48-55. PubMed ID: 28967230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the prevalence of and factors associated with overactive bladder in adult Korean women.
    Kim SY; Bang W; Choi HG
    PLoS One; 2017; 12(9):e0185592. PubMed ID: 28957446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
    Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
    Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.